The acquisition comes as Temple works to validate the science behind its wearable device, which is worn on the temple and is designed to track physiological signals. Goyal said Mohr and Roy had spent the past two months using the device and working with Temple’s scientists to pressure-test its data and the company’s “Entropy” metric.